Research progress of vulvovaginal candidiasis

doi:10.3969/j.issn.1673-8640.2016.08.020

Abstract

Abstract:

Candida is one of normal floras. It plays a role in maintaining vaginal normal flora at ecological balance and in vaginal self-purification process. Vulvovaginal candidiasis （VVC） is a common vaginal infection caused by Candida. The incidence is related to many factors,mainly the overgrowth of Candida. This article on VVC mainly includes its epidemiological characteristics,clinical classification,etiology,pathogenic mechanism,determination,diagnosis and treatment.

Key words: Vulvovaginal candidiasis, Candida, Research progress

CLC Number:

R379.4

WANG Dongjiang, WU Wenjuan. Research progress of vulvovaginal candidiasis[J]. Laboratory Medicine, 2016, 31(8): 721-727.

Figures/Tables 1

References 50

[1]	刘朝晖,廖秦平. 外阴阴道假丝酵母菌病(VVC)诊治规范修订稿[J]. 中国实用妇科与产科杂志,2012,28(6):401-402.
[2]	RATHOD SD,BUFFLER PA.Highly-cited estimates of the cumulative incidence and recurrence of vulvovaginal candidiasis are inadequately documented[J]. BMC Womens Health,2014,14(1):43.
[3]	AGUIN TJ,SOBEL JD.Vulvovaginal candidiasis in pregnancy[J]. Curr Infect Dis Rep,2015,17(6):462.
[4]	ZHANG JY,LIU JH,LIU FD,et al.Vulvovaginal candidiasis:species distribution,fluconazole resistance and drug efflux pump gene overexpression[J]. Mycoses,2014,57(10):584-591.
[5]	FOXMAN B,MURAGLIA R,DIETZ JP,et al.Prevalence of recurrent vulvovaginal candidiasis in 5 European countries and the United States:results from an internet panel survey[J]. J Low Genit Tract Dis,2013,17(3):340-345.
[6]	GOLDACRE MJ,WATT B,LOUDON N,et al.Vaginal microbial flora in normal young women[J]. Br Med J,1979,1(6176):1450-1453.
[7]	WATSON CJ,FAIRLEY CK,GRANDO D,et al.Associations with asymptomatic colonization with Candida in women reporting past vaginal candidiasis:an observational study[J]. Eur J Obstet Gynecol Reprod Biol,2013,169(2):376-379.
[8]	WORKOWSKI KA,BOLAN GA.Sexually transmitted diseases treatment guidelines,2015[J]. MMWR Recomm Rep,2015,64(33):924.
[9]	GUZEL AB,ILKIT M,AKAR T,et al.Evaluation of risk factors in patients with vulvovaginal candidiasis and the value of chromID Candida agar versus CHROMagar Candida for recovery and presumptive identification of vaginal yeast species[J]. Med Mycol,2011,49(1):16-25.
[10]	LIAN C,ZHAO J,ZHANG Z,et al.Genotype of Candida species associated with different conditions of vulvovaginal candidosis[J]. Mycoses,2004,47(11-12):495-502.
[11]	MACURA AB,VOSS A,MELCHERS WJ,et al.Characterization of pathogenetic determinants of Candida albicans strains[J]. Zentralbl Bakteriol,1998,287(4):501-508.
[12]	PIECUCH A,OBK E.Yeast ABC proteins involved in multidrug resistance[J]. Cell Mol Biol Lett,2014,19(1):1-22.
[13]	HAMEED S,FATIMA Z.Novel regulatory mechanisms of pathogenicity and virulence to combat MDR in Candida albicans[J]. Int J Microbiol,2013,2013:240209.
[14]	ROGERS PD,BARKER KS.Genome-wide expression profile analysis reveals coordinately regulated genes associated with stepwise acquisition of azole resistance in Candida albicans clinical isolates[J]. Antimicrob Agents Chemother,2003,47(4):1220-1227.
[15]	TAFF HT,MITCHELL KF,EDWARD JA,et al.Mechanisms of Candida biofilm drug resistance[J]. Future Microbiol,2013,8(10):1325-1337.
[16]	DOUGLAS LJ.Candida biofilms and their role in infection[J]. Trends Microbiol,2003,11(1):30-36.
[17]	COWEN LE,LINDQUIST S.Hsp90 potentiates the rapid evolution of new traits:drug resistance in diverse fungi[J]. Science,2005,309(5744):2185-2189.
[18]	O'MEARA TR,COWEN LE. Hsp90-dependent regulatory circuitry controlling temperature-dependent fungal development and virulence[J]. Cell Microbiol,2014,16(4):473-481.
[19]	FAN Y,HE H,DONG Y,et al.Hyphae-specific genes HGC1,ALS3,HWP1,and ECE1 and relevant signaling pathways in Candida albicans[J]. Mycopathologia,2013,176(5-6):329-335.
[20]	POLVI EJ,LI X,O'MEARA TR,et al.. Opportunistic yeast pathogens:reservoirs,virulence mechanisms,and therapeutic strategies[J]. Cell Mol Life Sci,2015,72(12):2261-2287.
[21]	SUN Y,CAO C,JIA W,et al.pH regulates white-opaque switching and sexual mating in Candida albicans[J]. Eukaryot Cell,2015,14(11):1127-1134.
[22]	DE BERNARDIS F,ARANCIA S,SANDINI S,et al.Studies of immune responses in Candida vaginitis[J]. Pathogens,2015,4(4):697-707.
[23]	SANDINI S,LA VALLE R,DEAGLIO S,et al.A highly immunogenic recombinant and truncated protein of the secreted aspartic proteases family (rSap2t) of Candida albicans as a mucosal anticandidal vaccine[J]. FEMS Immunol Med Microbiol,2011,62(2):215-224.
[24]	ACHKAR JM,FRIES BC.Candida infections of the genitourinary tract[J]. Clin Microbiol Rev,2010,23(2):253-273.
[25]	SRIKANTHA T,DANIELS KJ,WU W,et al.Dark brown is the more virulent of the switch phenotypes of Candida glabrata[J]. Microbiology,2008,154(Pt 11):3309-3318.
[26]	RIERA M,MOGENSEN E,D'ENFERT C,et al.. New regulators of biofilm development in Candida glabrata[J]. Res Microbiol,2012,163(4):297-307.
[27]	SILVA-DIAS A,MIRANDA IM,BRANCO J,et al.Adhesion,biofilm formation,cell surface hydrophobicity,and antifungal planktonic susceptibility:relationship among Candida spp.[J]. Front Microbiol,2015,6:205.
[28]	徐辉,仇萌,陈虹霞,等. 白念珠菌生物膜及其研究进展[J]. 中国真菌学杂志,2014,9(4):245-247.
[29]	SOLL DR.High-frequency switching in Candida albicans and its relations to vaginal candidiasis[J]. Am J Obstet Gynecol,1988,158(4):997-1001.
[30]	TAO L,DU H,GUAN G,et al.Discovery of a "white-gray-opaque" tristable phenotypic switching system in Candida albicans:roles of non-genetic diversity in host adaptation[J]. PLoS Biol,2014,12(4):e1001830.
[31]	ARAUJO PAULO DE MEDEIROS M,VIEIRA DE MELO AP,GONCALVES SS,et al. Genetic relatedness among vaginal and anal isolates of Candida albicans from women with vulvovaginal candidiasis in north-east Brazil[J]. J Med Microbiol,2014,63(Pt 11):1436-1445.
[32]	高飞,曹萍,吴颖,等. 外阴阴道念珠菌病复发与阴道及肛管白念珠菌定植关系的研究[J]. 皮肤病与性病,2014,37(3):129-130.
[33]	LIU MB,XU SR,HE Y,et al.Diverse vaginal microbiomes in reproductive-age women with vulvovaginal candidiasis[J]. PLoS ONE,2013,8(11):e79812.
[34]	AMOURI I,HADRICH I,ABBES S,et al.Local humoral immunity in vulvovaginal candidiasis[J]. Ann Biol Clin(Paris),2013,71(2):151-155.
[35]	YANO J,NOVERR MC,FIDEL PL JR.Cytokines in the host response to Candida vaginitis:identifying a role for non-classical immune mediators,S100 alarmins[J]. Cytokine,2012,58(1):118-128.
[36]	FILLER SG.Insights from human studies into the host defense against candidiasis[J]. Cytokine,2012,58(1):129-132.
[37]	SOBEL JD.Recurrent vulvovaginal candidiasis[J]. Am J Obstet Gynecol,2016,214(1):15-21.
[38]	CHAIM W,FOXMAN B,SOBEL JD.Association of recurrent vaginal candidiasis and secretory ABO and Lewis phenotype[J]. J Infect Dis,1997,176(3):828-830.
[39]	BABULA O,LAZDANE G,KROICA J,et al.Frequency of interleukin-4(IL-4) -589 gene polymorphism and vaginal concentrations of IL-4,nitric oxide,and mannose-binding lectin in women with recurrent vulvovaginal candidiasis[J]. Clin Infect Dis,2005,40(9):1258-1262.
[40]	TARRY W,FISHER M,SHEN S,et al.Candida albicans:the estrogen target for vaginal colonization[J]. J Surg Res,2005,129(2):278-282.
[41]	DENNERSTEIN GJ,ELLIS DH.Oestrogen,glycogen and vaginal candidiasis[J]. Aust N Z J Obstet Gynaecol,2001,41(3):326-328.
[42]	ATABEK ME,AKYREK N,EKLIOGLU BS.Frequency of vaginal Candida colonization and relationship between metabolic parameters in children with type 1 diabetes mellitus[J]. J Pediatr Adolesc Gynecol,2013,26(5):257-260.
[43]	BASSYOUNI RH,WEGDAN AA,ABDELMONEIM A,et al.Phospholipase and aspartyl proteinase activities of Candida species causing vulvovaginal candidiasis in patients with type 2 diabetes mellitus[J]. J Microbiol Biotechnol,2015,25(10):1734-1741.
[44]	GOSWAMI R,DADHWAL V,TEJASWI S,et al.Species-specific prevalence of vaginal candidiasis among patients with diabetes mellitus and its relation to their glycaemic status[J]. J Infect,2000,41(2):162-166.
[45]	WRIGHT J,PAAUW DS.Complications of antibiotic therapy[J]. Med Clin North Am,2013,97(4):667-679.
[46]	WILTON L,KOLLAROVA M,HEELEY E,et al.Relative risk of vaginal candidiasis after use of antibiotics compared with antidepressants in women:postmarketing surveillance data in England[J]. Drug Saf,2003,26(8):589-597.
[47]	赵学静,朱爱琴. 乳酸杆菌在细菌性阴道病诊断中的作用[J]. 中华医院感染学杂志,2010,20(7):1023-1024.
[48]	高晓红,朱玲. 复发性外阴阴道假丝酵母菌病与阴道免疫[J]. 中国免疫学杂志,2014,30(7):985-987.
[49]	闵洁,王敏,赵健洁,等. 念珠菌性阴道炎病理变化与机体免疫反应的关系[J]. 中国妇幼保健,2009,24(28):4016-4018.
[50]	VONK AG,NETEA MG,VAN DER MEER JW,et al. Host defence against disseminated Candida albicans infection and implications for antifungal immunotherapy[J]. Expert Opin Biol Ther,2006,6(9):891-903.

临床症状	0 分	1 分	2 分	3 分
疼痛	无	轻度	中度	重度
充血、水肿	无	轻度	中度	重度
抓痕、皲裂、糜烂	无	—	—	有
分泌物量	无	较正常稍多	量多,无溢出	量多,有溢出

临床症状	0 分	1 分	2 分	3 分
疼痛	无	轻度	中度	重度
充血、水肿	无	轻度	中度	重度
抓痕、皲裂、糜烂	无	—	—	有
分泌物量	无	较正常稍多	量多,无溢出	量多,有溢出